Membrane technology is generally utilized as a part of different advancement phases of pharmaceutical, biopharmaceutical and life sciences industries. It incorporates applications from laboratory medication exploration to large-scale pharmaceutical production. Applications of membrane technology in pharmaceutical, life sciences, and biopharmaceutical commercial enterprises incorporate lab-scale DNA and protein separation and investigation, drug screening, cell culturing, and examination and virus evacuation. The global membrane technology market in the pharmaceutical, biopharmaceutical, and life science industries is expected to expand at a CAGR of 9.1% between 2014 and 2019 to reach US$10,886.0 million in 2019, as established by Persistence Market Research in a recent market study.
Apart from offering a wide range of products and applications in the pharmaceutical, biopharmaceutical, and life sciences industries, membrane technology helps in the production of microarray products, multiwell filters, syringe membranes filters and bottle top filters. They have numerous applications in life sciences and biopharmaceutical industries.
In this blog post, PMR answers three critical questions about the membrane technology market:
Q. What factors can be identified as core drivers of the membrane technology market?
A. Globally, the membrane technology market is developing because of expanding research,
production, and development in pharmaceutical, biopharmaceutical, and life sciences industries. There has been a considerable increase in the quantity of membrane technology applications, including division and refinement of drug components, in industries related to pharmaceutical, biopharmaceutical, and life sciences. Consequently, growth in pharmaceutical production and expanding number of membrane technology applications all around the world are driving the development of membrane technology in pharmaceutical, biopharmaceutical, and life sciences industries.
Q. What are the market forces that will work against the growth of membrane technology?
A. Firstly, soaring capital and rising operational expenses will restrain the development of the the membrane technology market in commercial enterprises in the pharmaceutical, life sciences, and biopharmaceutical industries. The second critical component that will suppress the development of the membrane technology market is membrane fouling, which is a significant concern with the membrane technology, as it abates membrane productivity. To keep this from happening, membrane filters need to be supplanted or washed every three to four years to evacuate foulants.
Q. Which region will be the leading segment in membrane technology by 2019?
A. On the basis of geographic segmentation, North America has the biggest market for membrane technology in biopharma, pharmaceutical, and life sciences. The U.S. is the world’s biggest market for biopharmaceutical and pharmaceutical items. Due to the development of the pharmaceutical and biopharmaceutical industries, demand for membrane filtration will grow in North America in the coming few years.
Asia is the quickest developing regional segment of the market for membrane technology in pharmaceutical, biopharma, and life sciences. This region is developing quickly because of consistent improvement in the pharmaceutical and biopharmaceutical industries. Additionally, Asia is witnessing development in the pharmaceutical and biopharmaceutical industries because of a vast population pool, expanding healthcare awareness, rising frequency of chronic ailments, and rising government healthcare spending.
Some of the key players in the membrane technology market for biopharma, pharmaceutical, and life sciences industry are Pall Corporation, GE Healthcare Life Sciences, Merck Millipore, Sartorius, and 3M.